Dose–response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate

類似資料

• Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate
  著者:: Lipworth, B J, 等
  出版事項: (1999)
• Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma
  著者:: Currie, G, 等
  出版事項: (2002)
• Systemic bioavailability of hydrofluoroalkane formulations containing fluticasone propionate and salmeterol
  著者:: Daley-Yates, Peter T, 等
  出版事項: (2011)
• Fluticasone propionate v beclomethasone dipropionate (BDP) in moderate to severe asthma.
  著者:: O'Driscoll, R.
  出版事項: (1994)
• Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients
  著者:: Clark, D. J., 等
  出版事項: (1997)